Live from the NIH registry
Studies recruiting near Spring Hill right now
Top 25 of 110 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
FL Medical Clinic Orlando Health — Zephyrhills, Florida (27.2 mi)
· Sponsor: Novartis Pharmaceuticals
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Advanced Research Institute, Inc — New Port Richey, Florida (19.9 mi)
· Sponsor: Philip Morris Products S.A.
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
New Port Richey — New Port Richey, Florida (19.9 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Suncoast Clinical Research, Inc — New Port Richey, Florida (19.9 mi)
· Sponsor: Sparrow Pharmaceuticals
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Brooksville, Florida (10.0 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — New Port Richey, Florida (19.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Nature Coast Clinical Research - Inverness — Inverness, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Suncoast Clinical Research — New Port Richey, Florida (19.9 mi)
· Sponsor: Zucara Therapeutics Inc.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: NRG Oncology
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Asthma
Phase 3
Interventional 150 participants sought
GSK Investigational Site — Brooksville, Florida (10.0 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Crystal River, Florida (29.5 mi)
· Sponsor: AstraZeneca
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Suncoast Clinical Research — New Port Richey, Florida (19.9 mi)
· Sponsor: Boehringer Ingelheim
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Cardiovascular, Metabolic Disease
Phase 1
Interventional 90 participants sought
Research Site 19 — High Point, Florida (4.6 mi)
· Sponsor: CRISPR Therapeutics AG
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Crystal River, Florida (29.5 mi)
· Sponsor: AstraZeneca
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Access Research Institute — Brooksville, Florida (10.0 mi)
· Sponsor: Hoffmann-La Roche
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: NRG Oncology
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: National Cancer Institute (NCI)
FebriDx® Pediatric Validation Study
Acute Respiratory Infections (ARIs)
N/A
Observational 800 participants sought
PAS Research- Sandhill Pediatrics PA — Lutz, Florida (23.1 mi)
· Sponsor: Lumos Diagnostics
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (20.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Nature Coast Clinical Research — Inverness, Florida (27.4 mi)
· Sponsor: Janssen Research & Development, LLC
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
Healthy Aging, Anti Aging
N/A
Interventional 80 participants sought
MusB Research LLC — New Port Richey, Florida (19.9 mi)
· Sponsor: Synbiotic Health
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Brooksville, FL Investigative Site 10077 — Brooksville, Florida (10.0 mi)
· Sponsor: Colorado Prevention Center
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Zephyrhills, Florida (27.2 mi)
· Sponsor: MoonLake Immunotherapeutics AG
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Peripheral Artery Disease (PAD)
Phase 3
Interventional 7,050 participants sought
Nature Coast Clinical Research - Cardiology — Crystal River, Florida (29.5 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Access Research Institute — Brooksville, Florida (10.0 mi)
· Sponsor: Uniquity One (UNI)